847538786	847538786	CD	B-NP	O
|	|	NN	I-NP	O
CMC	CMC	NN	I-NP	O
|	|	NN	I-NP	O
04131886	04131886	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6571879	6571879	CD	B-NP	O
|	|	CC	I-NP	O
5/5/2005	5/5/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
Exacerbation	Exacerbation	NNP	I-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/5/2005	5/5/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/9/2005	10/9/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
WONSER	WONSER	NN	I-NP	O
,	,	,	O	O
MOHAMED	MOHAMED	VBD	B-VP	O
884-85-58-3	884-85-58-3	CD	B-NP	O
Otte	Otte	NNP	I-NP	O
Lake	Lake	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/8/05	1/8/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BOLAND	BOLAND	NNP	B-NP	O
,	,	,	O	O
DEAN	DEAN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/05	2/8/05	CD	B-NP	O
by	by	IN	B-PP	O
MULLINGS	MULLINGS	NNP	B-NP	O
,	,	,	O	O
BRICE	BRICE	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
092810015	092810015	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NAPROXEN	NAPROXEN	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
muscle	muscle	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
outpt	outpt	JJ	B-NP	O
med	med	JJ	I-NP	O
CATAPRES	CATAPRES	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	O
CLONIDINE	CLONIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
TP	TP	NN	I-NP	O
Q168H	Q168H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
place	place	NN	B-NP	O
2	2	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
patches	patch	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/18/05	11/18/05	CD	B-NP	O
by	by	IN	B-PP	O
CORP	CORP	NN	B-NP	B-protein
,	,	,	O	O
TIM	TIM	NN	B-NP	B-protein
A.	A.	NN	I-NP	I-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
100201175	100201175	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
URIN	URIN	NNP	B-NP	O
HESITANCY	HESITANCY	NNP	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
PRAVASTATIN	PRAVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/05	2/8/05	CD	B-NP	O
by	by	IN	B-PP	O
MAHARREY	MAHARREY	NNP	B-NP	O
,	,	,	O	O
ELIJAH	ELIJAH	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
649531397	649531397	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
LOVASTATIN	LOVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Muscle	Muscle	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ATORVASTATIN	ATORVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
leg	leg	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
out	out	IN	B-SBAR	O
pt	pt	NN	B-NP	B-DNA
med	me	VBD	B-VP	I-DNA
NORVASC	NORVASC	NNP	B-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
AMLODIPINE	AMLODIPINE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/05	2/8/05	CD	B-NP	O
by	by	IN	B-PP	O
LITVAK	LITVAK	NNP	B-NP	O
,	,	,	O	O
BOOKER	BOOKER	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NORVASC	NORVASC	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
529794170	529794170	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NIFEDIPINE	NIFEDIPINE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
CONSTIPATION	CONSTIPATION	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
outpt	outpt	NN	B-NP	O
med	me	VBD	B-VP	O
IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
90	90	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/22	6/22	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIOVAN	DIOVAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/05	2/8/05	CD	B-NP	O
by	by	IN	B-PP	O
ZIMBA	ZIMBA	NNP	B-NP	O
,	,	,	O	O
FRANK	FRANK	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIOVAN	DIOVAN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
875873573	875873573	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
LOSARTAN	LOSARTAN	NN	B-NP	O
POTASSIUM	POTASSIUM	NN	I-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
facial	facial	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
FACIAL	FACIAL	NNP	B-NP	O
SWELLING/ITCH	SWELLING/ITCH	NNP	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
outpt	outpt	NN	B-NP	O
med	me	VBD	B-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1000	1000	CD	B-NP	O
BECONASE	BECONASE	NNP	I-NP	O
AQ	AQ	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BECLOMETHASONE	BECLOMETHASONE	NNP	I-NP	O
DIPROPIONATE	DIPROPIONATE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
ACULAR	ACULAR	NN	I-NP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
KETOROLAC	KETOROLAC	NN	I-NP	O
TROMETHAMINE	TROMETHAMINE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
DROP	DROP	NN	I-NP	O
OS	OS	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/19/05	10/19/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACULAR	ACULAR	NN	B-NP	O
0.5	0.5	CD	I-NP	O
%	%	NN	I-NP	O
OS	OS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
918405480	918405480	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NAPROXEN	NAPROXEN	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
muscle	muscle	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
used	use	VBN	I-VP	O
these	these	DT	B-NP	O
eyedrops	eyedrop	NNS	I-NP	O
without	without	IN	B-PP	O
side	side	NN	B-NP	B-protein
effect	effect	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
90	90	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
ATENOLOL	ATENOLOL	NN	B-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
CARDURA	CARDURA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOXAZOSIN	DOXAZOSIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LORATADINE	LORATADINE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
NTG	NTG	NNP	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	SYM	O	I-protein
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/24	9/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
TESSALON	TESSALON	NNP	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
Walking	Walking	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Faraone	Faraone	NNP	I-NP	O
9/24	9/24	CD	I-NP	O
@	@	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Daine	Daine	NNP	I-NP	O
10/13	10/13	CD	I-NP	O
@	@	NN	I-NP	O
1pm	1pm	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Norberto	Norberto	NNP	I-NP	O
Fujiwara	Fujiwara	NNP	I-NP	O
,	,	,	O	O
Sontia	Sontia	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Systems	Systems	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/1	9/1	CD	I-NP	O
@	@	.	O	O
4	4	CD	B-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
CARBAMAZEPINE	CARBAMAZEPINE	NNP	B-NP	O
,	,	,	O	O
LOSARTAN	LOSARTAN	NNP	B-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
,	,	,	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
,	,	,	O	O
FAMOTIDINE	FAMOTIDINE	NNP	B-NP	O
,	,	,	O	O
NIFEDIPINE	NIFEDIPINE	NNP	B-NP	O
,	,	,	O	O
LOVASTATIN	LOVASTATIN	NNP	B-NP	O
,	,	,	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
,	,	,	O	O
NAPROXEN	NAPROXEN	NNP	B-NP	O
,	,	,	O	O
nutrasweet	nutrasweet	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NNP	B-NP	O
Exacerbation	Exacerbation	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
Exacerbation	Exacerbation	NNP	I-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cri	cri	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NQWMI	NQWMI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
2v	2v	CD	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
high	high	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Adenosine	Adenosine	NNP	I-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	O	O
Echocardiogram	Echocardiogram	NNP	B-NP	O
,	,	,	O	O
Cardiac	Cardiac	NNP	B-NP	O
Catheterization	Catheterization	NNP	I-NP	O
with	with	IN	B-PP	O
Circumflex	Circumflex	NNP	B-NP	O
and	and	CC	O	O
LAD	LAD	NNP	B-NP	O
Stent	Stent	NNP	I-NP	O
Placement	Placement	NNP	I-NP	O
,	,	,	O	O
Renal	Renal	NNP	B-NP	O
Angiogram	Angiogram	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
******************	******************	SYM	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
78F	78F	NN	B-NP	O
c	c	NN	I-NP	O
hx/o	hx/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
c	c	NN	I-NP	O
EF	EF	NN	I-NP	O
40-45	40-45	CD	B-NP	O
%	%	NN	I-NP	O
as	as	IN	B-PP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
and	and	CC	O	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
x	x	SYM	B-VP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
self-d/c	self-d/c	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	O
meds	med	NNS	I-NP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Assc	Assc	NN	B-NP	O
sxs	sx	NNS	I-NP	O
include	include	VBP	B-VP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
c	c	NN	I-NP	O
clr	clr	NN	I-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
night	night	NN	B-NP	O
sweats	sweat	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
bilat	bilat	NN	B-NP	O
CP	CP	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
of	of	IN	B-PP	O
EMS	EMS	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afeb	afeb	JJ	B-NP	O
c	c	NN	I-NP	O
BP	BP	NN	I-NP	O
of	of	IN	B-PP	O
180/100	180/100	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
captopril	captopril	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
,	,	,	O	O
c	c	NN	B-VP	O
some	some	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

******************	******************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
MI/CABG	MI/CABG	NN	B-NP	O
1998	1998	CD	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
c	c	NN	I-NP	O
retinopathy/nephropathy	retinopathy/nephropathy	NN	I-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
OA	OA	NN	B-NP	O
,	,	,	O	O
Leukocytosis	Leukocytosis	NN	B-NP	O
.	.	.	O	O

MEDS	MEDS	NNS	B-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	B-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Beconase	Beconase	NNP	B-NP	O
42	42	CD	I-NP	O
mcg	mcg	NN	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
Cardura	Cardura	NNP	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
160mg	160mg	VBD	B-VP	O
PO	PO	NNP	B-NP	O
BID	BID	NNP	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NNP	B-NP	O
25mg	25mg	VBD	B-VP	O
PO	PO	NNP	B-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
ER	ER	NNP	I-NP	B-protein
60mg	60mg	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
40mg	40mg	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Loratidine	Loratidine	NNP	B-NP	O
10mg	10mg	VBD	B-VP	O
PO	PO	NNP	B-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
100mg	100mg	VBD	B-VP	O
PO	PO	NNP	B-NP	O
TID	TID	NNP	I-NP	O
,	,	,	O	O
NTG	NTG	NNP	B-NP	O
.4	.4	CD	I-NP	O
mg	mg	NN	I-NP	O
PRN	PRN	NN	I-NP	O
CP	CP	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10mg	10mg	VBD	B-VP	O
PO	PO	NNP	B-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Pavachol	Pavachol	NNP	B-NP	O
80mg	80mg	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
:	:	:	O	O
PCN	PCN	NN	B-NP	B-protein
-	-	HYPH	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
Carbamazepine	Carbamazepine	NN	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
Losartan	Losartan	NNP	B-NP	O
facial	facial	JJ	I-NP	O
swelling	swell	VBG	I-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
Nutrasweet	Nutrasweet	NNP	B-NP	O
throat	throat	IN	B-PP	O
swelling	swell	VBG	B-NP	O
,	,	,	O	O
Enalapril	Enalapril	NNP	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
Famotidine	Famotidine	NN	B-NP	O
dry	dry	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
Nifedipine	Nifedipine	NN	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NN	B-NP	B-protein
urinary	urinary	JJ	I-NP	O
hesitancy	hesitancy	NN	I-NP	O
,	,	,	O	O
Lovastatin	Lovastatin	NN	B-NP	O
muscle	muscle	NN	I-NP	O
cramps	cramp	NNS	I-NP	O
,	,	,	O	O
Atorvastatin	Atorvastatin	NN	B-NP	O
leg	leg	NN	I-NP	O
cramps	cramp	NNS	I-NP	O
,	,	,	O	O
Naproxen	Naproxen	NNP	B-NP	O
muscle	muscle	NN	I-NP	O
cramps	cramp	NNS	I-NP	O
******************	******************	SYM	B-NP	O
STATUS	STATUS	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
PHYS	PHYS	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
T98	T98	NN	B-NP	B-protein
P	P	NN	I-NP	I-protein
65	65	CD	B-NP	I-protein
BP	BP	NN	I-NP	I-protein
146/60	146/60	CD	B-NP	I-protein
RR	RR	NN	I-NP	I-protein
22	22	CD	B-NP	I-protein
O2	O2	NN	I-NP	I-protein
sat	sit	VBD	B-VP	I-protein
98	98	CD	B-NP	I-protein
NAD	NAD	NN	I-NP	I-protein
c	c	NN	I-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NNP	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
M/R/G	M/R/G	NN	I-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
NT/ND	NT/ND	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
LE	LE	NN	B-NP	O
weak	weak	JJ	B-ADJP	O
,	,	,	O	O
DTR	DTR	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
CN	CN	NN	B-NP	B-protein
II-XII	II-XII	NN	I-NP	I-protein
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

******************	******************	SYM	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
LABS	LABS	NN	B-NP	B-protein
-	-	HYPH	O	O
BNP	BNP	NN	B-NP	B-protein
673	673	CD	I-NP	I-protein
;	;	:	O	O
TNI	TNI	NN	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
CR	CR	NN	B-NP	B-protein
0.9	0.9	CD	I-NP	I-protein
;	;	:	O	O
WBC	WBC	NNP	B-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-protein
5.2	5.2	CD	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
EKG	EKG	NN	I-NP	O
-	-	HYPH	B-NP	O
LBBB	LBBB	NN	I-NP	B-protein
,	,	,	O	O
NSR	NSR	NN	B-NP	B-protein
******************	******************	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
i	i	AFX	O	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
c	c	NN	B-NP	O
worsening	worsen	VBG	B-VP	O
atypical	atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
first	first	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
neg	neg	NN	I-NP	O
,	,	,	O	O
second	second	JJ	B-NP	O
set	set	NN	I-NP	O
pos	po	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
TNI-2	TNI-2	NN	B-NP	B-protein
.93	.93	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
anticoagulated	anticoagulate	VBN	B-VP	O
with	with	IN	B-PP	O
SC	SC	NN	B-NP	B-protein
lovenox	lovenox	NN	I-NP	I-protein
,	,	,	O	O
third	third	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
trending	trend	VBG	B-VP	O
down	down	IN	B-ADVP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
on	on	IN	B-PP	O
11/10	11/10	CD	B-NP	O
,	,	,	O	O
reversible	reversible	JJ	B-NP	O
inferolateral	inferolateral	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
concurrent	concurrent	JJ	B-NP	O
renal	renal	JJ	I-NP	O
angiogram	angiogram	NN	I-NP	O
for	for	IN	B-PP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
HTN	HTN	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
three	three	CD	B-NP	O
vessel	vessel	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LMCA	LMCA	NNP	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
CX	CX	NN	B-NP	O
70-80	70-80	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
1/2	1/2	CD	B-NP	O
grafts	graft	NNS	I-NP	O
patent	patent	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Stents	Stent	NNS	B-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
CX	CX	NN	B-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

S/P	S/P	NN	B-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
29	29	CD	B-NP	O
-LRB-	-LRB-	HYPH	O	O
39	39	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
Creatinine	Creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
.9	.9	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Patient	Patient	JJ	B-NP	O
given	give	VBN	I-NP	O
mucomyst	mucomyst	NN	I-NP	O
with	with	IN	B-PP	O
discharge	discharge	NN	B-NP	O
HCT	HCT	NN	I-NP	O
32	32	CD	I-NP	O
and	and	CC	O	O
Cr	Cr	NN	B-NP	O
of	of	IN	B-PP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
effectively	effectively	RB	B-ADVP	O
with	with	IN	B-PP	O
20mg	20mg	NN	B-NP	O
IV	IV	CD	B-NP	O
boluses	bolus	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
UOP	UOP	NN	I-NP	O
.	.	.	O	O

Euvolemic	Euvolemic	JJ	B-ADJP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
requiring	require	VBG	B-VP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
-	-	HYPH	O	O
BP	BP	NN	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

Titrated	Titrate	VBN	B-VP	O
up	up	RP	B-PRT	O
lopressor	lopressor	NN	B-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
q6hr	q6hr	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
added	add	VBN	I-NP	O
25mg	25mg	NN	I-NP	O
HCTZ	HCTZ	NN	I-NP	O
and	and	CC	O	O
hydral	hydral	JJ	B-NP	O
PRN	PRN	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
very	very	RB	B-NP	O
high	high	JJ	I-NP	O
SBP	SBP	NN	I-NP	B-protein
spikes	spike	VBZ	B-VP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
angiogram	angiogram	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Aron	Aron	NNP	I-NP	O
Wyndham	Wyndham	NNP	I-NP	O
on	on	IN	B-PP	O
10/14	10/14	CD	B-NP	O
Echo	Echo	NNP	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	I-NP	O
nebs	neb	NNS	I-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
transiently	transiently	RB	I-NP	O
inc	inc	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
patient	patient	NN	I-NP	O
now	now	RB	B-VP	O
weaned	wean	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Leukocytosis	Leukocytosis	NN	B-NP	O
-	-	HYPH	O	O
WBC	WBC	NN	B-NP	B-DNA
22	22	CD	I-NP	I-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
c	c	NN	I-NP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infxn	infxn	NN	B-NP	O
and	and	CC	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
17	17	CD	I-NP	O
on	on	IN	B-PP	O
10/5	10/5	CD	B-NP	O
,	,	,	O	O
c	c	NN	B-NP	O
temp	temp	NN	I-NP	O
of	of	IN	B-PP	O
100.3	100.3	CD	B-NP	O
,	,	,	O	O
inc	inc	NN	B-NP	O
SOB	SOB	NN	I-NP	O
and	and	CC	O	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
so	so	IN	B-SBAR	O
Levoquin	Levoquin	NNP	B-NP	O
started	start	VBD	B-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
PNA	PNA	NN	I-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
12	12	CD	I-NP	O
on	on	IN	B-PP	O
8/17	8/17	CD	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
lantus	lantus	NN	I-NP	O
40U	40U	NN	I-NP	O
.	.	.	O	O

SS	SS	NN	B-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
medicines	medicine	NNS	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
before	before	IN	B-PP	O
coming	come	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
noting	note	VBG	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
-LRB-	-LRB-	NNP	B-NP	O
Imdur	Imdur	NNP	I-NP	O
90mg	90mg	VBD	B-VP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75mg	75mg	CD	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
ninety	ninety	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
150mg	150mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
two	two	CD	B-NP	O
more	more	JJR	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SOULA	SOULA	NNP	B-NP	O
,	,	,	O	O
IRVING	IRVING	NNP	B-NP	O
A.	A.	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/8/05	1/8/05	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
04	04	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

